Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure

European Heart Journal

Volumn 28, Issue 5, 2007, Pages 560-568

  Ingle, Lee ^a   Rigby, Alan S ^b   Carroll, Sean ^a   Butterly, Ron ^a   King, Rod F ^a   Cooke, Carlton B ^a   Cleland, John G J F ^b   Clark, Andrew L ^b  

^a LEEDS METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Chronic heart failure; Exercise; Prognosis; Survival

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SELF CONCEPT; SURVIVAL; WALKING;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT; WALKING;

EID: 34547813143     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl527     Document Type: Article

References (61)

1. Cleland JG, Charlesworth A, Lubsen J, Swedberg K, Remme WJ, Erhardt L, Di Lenarda A, Komajda M, Metra M, Torp-Pedersen C, Poole-Wilson PA, COMET Investigators. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the 'patient journey') in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET). J Am Coll Cardiol 2006;8:1603-1611.
2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;15:1539-1549.
3. Schalcher C, Brehm H, Rickli M. Prolonged oxygen uptake kinetics during low-intensity exercise are related to poor prognosis in patients with mild-to-moderate congestive heart failure. Chest 2003;124:580-586.
4. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-786.
5. Gitt AK, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M, Schneider S, Schwarz A, Senges J. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002;106:3079-3084.
6. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, Poole-Wilson PA, Coats AJ. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585-1590.
7. Clark AL, Volterrani M, Swan JW. The ventilatory response to exercise in chronic heart failure: relation to pulmonary pathology. Heart 1997;77:138-146.
8. Ingle L, Wilkinson M, Carroll S, Boyes C, Cleland JGF, Clark AL. Cardiorespiratory requirements of the 6-min walk test in older patients with left ventricular systolic dysfunction and no major structural heart disease. Int J Sports Med 2006; in press.
9. Crapo RO, Casaburi R, Coates AL, Enright PL, MacIntyre NR, McKay RT, Johnson D, Wanger JS, Zeballos RJ, Bittner V, Mottram C. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:1111-1117.
10. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB. The six minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-923.
11. Ingle L, Shelton RJ, Rigby AS, Nabb S, Clark AL, Cleland JG. The reproducibility and sensitivity of the six-minute walk test in patients with chronic heart failure. Eur Heart J 2005;26:1742-1751.
12. Lipkin DP, Scriven AJ, Crake T, Poole-Wilson PA. Six-minute walking test for assessing exercise capacity in chronic heart failure. Br Med J 1986;292:653-655.
13. Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG. Six minute corridor walk test as an outcome measure for the assessment and treatment in randomised, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005;26:778-793.
14. Cahalin LP, Mathier MA, Semigran MJ, Dec GW, DiSalvo TG. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1996;110:325-332.
15. Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillotte M. For the SOLVD investigators: prediction of mortality and morbidity with a 6 min walk test in patients with left ventricular dysfunction. JAMA 1993;270:1702-1707.
16. Cahalin LP, Mathier MA, Semigran MJ, Dec WG, DiSalvo TM. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1996;110:325-332.
17. Roul G, German P, Bareiss P. Does the 6 min walk test predict the prognosis in patients with NYHA class II and III heart failure? Am Heart J 1998;136:449-457.
18. Lucas C, Stevenson LW, Johnson W, Hartley H, Hamilton MA, Walden J, Lem V, Eagen-Bengsten E. The 6 min walk test and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J 1999;138:618-624.
19. Rostagno C, Olivo G, Comeglio M, Boddi V, Banchelli M, Galanti G, Gensini GF. Prognostic value of 6 min walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail 2003;5:247-252.
20. National Institute for Clinical Excellence (NICE). Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care. London: NICE; 2003. Vol. 5, Clinical Guidelines.
21. Remme WJ, Swedberg K. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure: task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 2002;4:11-22.
22. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-367.
23. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002;359:1686-1689.
24. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-526.
25. Murray GD. A cautionary note on selection of variables in discriminant analysis. Appl Stat 1977;26:246-250.
26. Derkson S, Keselman J. Backward, forward and stepwise automated subset selection algorithms: frequency of obtaining authentic and noise variables. Br J Math Stat Psychol 1992;45:265-282.
27. Freedman LS, Pee D, Midthune DN. The problem of underestimating the residual error variance in forward stepwise regression. Statistician 1992;41:405-412.
28. Miller AJ. Selection of subsets of regression variables (with discussion). J R Stat Soc A 1984;147:389-425.
29. Freedman LS. A note on screening regression equations. Am Stat 1983;37:152-155.
30. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. London: Chapman and Hall; 1993.
31. Efron B, Tibshirani RJ. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sc 1986;1:54-77.
32. Burr D. A comparison of certain bootstrap confidence intervals in the Cox model. J Am Stat Assoc 1994;89:1290-1302.
33. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med 1992;11:2093-2109.
34. Mantel N. Why stepdown procedures in variable selection. Technometrics 1970;12:621-625.
35. Cox DR, Snell EJ. Analysis of Binary Data. Second Edition. London: Chapman and Hall; 1989.
36. Verweij PJM, van Houwelingen HC. Cross-validation in survival analysis. Stat Med 1993;12:2305-2314.
37. Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics with Confidence. 2nd. London: BMJ; 2000.
38. Perneger TV. What's wrong with Bonferonni adjustments? BMJ 1998;316:1236-1238.
39. Sauerbrei W. The use of resampling methods to simplify regression models in medical statistics. Appl Stat 1999;48:313-329.
40. Ingle L, Rigby AS, Nabb S, Jones PK, Clark AL, Cleland JG. Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease. Eur J Heart Fail 2006;8:321-325.
41. Clark AL, Poole-Wilson P, Coats AJ. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 1996;28:1092-1102.
42. Clark AL. Origin of symptoms in chronic heart failure. Heart 2006;92:12-16.
43. Volterrani M, Clark AL, Ludman PF. Determinants of exercise capacity in chronic heart failure. Eur Heart J 1994;15:801-809. [Abstract].
44. Buller NP, Jones D, Poole-Wilson PA. Direct measurements of skeletal muscle fatigue in patients with chronic heart failure. Br Heart J 1991;65:20-24. [Abstract].
45. Minotti JR, Pillay P, Chang L, Wells L, Massie BM. Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation 1992;86:903-908.
46. Franciosa JA. Why patients with heart failure die: hemodynamic and functional determinants of survival. Circulation 1987;75(Suppl. IV):20-27.
47. 2 determination in chronic heart failure: is it still of value? Eur Heart J 1994;15:495-502.
48. Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, Smith R, Fletcher R. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993;87:VI5-VI16.
49. Swedberg K, Eneroth P, Kjekshus J Wilhelmsen L. Hormone regulation of cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-1736.
50. Wieczorek SJ, Hager D, Barry MB, Kearney L, Ferrier A, Wu AH. Correlation of B-type natriuretic peptide level to 6-min walk test performance in patients with left ventricular systolic dysfunction. Clin Chim Acta 2003;328:87-90.
51. Hogenhuis J, Jaarsma T, Voors AA, Hillege HL, Lesman I, van Veldhuisen DJ. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients. Int J Cardiol 2006;1:63-67.
52. Box GEP. Statistics and Science. J Am Stat Assoc 1976;71:791-799.
53. Bendel RB, Afifi AA. Comparison of stopping rules in forward 'stepwise' regression. J Am Stat Assoc 1977;72:46-53.
54. Butler RW. Bounds on the significance attained by the best-fitting regressor variable. Appl Stat 1982;31:290-292.
55. Costanza MC, Afifi AA. Comparison of stopping rules in forward stepwise discriminant analysis. J Am Stat Assoc 1979;74:777-785.
56. Leger C, Altman N. Assessing influence in variable selection problems. J Am Stat Assoc 1993;88:547-556.
57. George EI. The variable selection problem. J Am Stat Assoc 2000;95:1304-1307.
58. Kuk AY. All subsets regression in a proportional hazards model. Biometrika 1984;71:587-592.
59. Reingold EM, Nievergelt J, Deo N. Combinatorial Algorithms: Theory and Practice. New Jersey: Prentice Hall; 1979.
60. Young GA. Bootstrap: more than a stab in the dark. Rejoinder. Stat Sci 1994;9:411-415.
61. Efron B. The bootstrap and modern statistics. J Am Stat Ass 2000;95:1293-1296.